September 11, 2024
The glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide is the first in its class to show benefits in young children with obesity, according to results from the […]
September 11, 2024
TOPLINE: MRI-derived abdominal adipose tissue is linked to chronic musculoskeletal pain in multiple sites. The association is stronger in women, suggesting sex differences in fat distribution […]
September 11, 2024
MADRID, Spain — Eli Lilly’s investigational once-weekly basal insulin analog efsitora alfa continues to show noninferiority to once-daily insulin in people with type 2 diabetes. However, […]
September 11, 2024
TOPLINE: Elevated interleukin (IL) 6 levels are associated with an increased risk for obesity-related cancers in patients newly diagnosed with type 2 diabetes (T2D), potentially enabling […]
September 11, 2024
MADRID — An artificial intelligence (AI)-driven voice algorithm showed “excellent agreement” with the American Diabetes Association (ADA) risk test in detecting adults with type 2 diabetes […]
September 10, 2024
MADRID, Spain — The nonsteroidal mineralocorticoid receptor antagonist (MRA) finerenone reduced the incidence of new-onset type 2 diabetes by approximately 25% in patients with heart failure […]
September 10, 2024
MADRID, Spain — Nearly half of people with type 2 diabetes (T2D) currently recommended to receive sodium-glucose cotransporter 2 (SGLT2) inhibitors for kidney protection would not […]
September 10, 2024
MADRID — Night owls — individuals with late chronotypes — may be at an increased risk for type 2 diabetes (T2D), beyond the risks conferred by […]
September 9, 2024
TOPLINE: MADRID — Impaired circadian heart rate (HR) fluctuations are linked to increased cardiovascular and all-cause mortality in patients with long-standing diabetes. METHODOLOGY: Researchers analyzed data […]